Parallele Bioscience

Genetic variation study tools for human health and drug development

placeSan Francisco, California, United States calendar_todayFounded 2001 language parallelebio.com

Innovation

6 patent families (1 granted) — focus: Chemistry & metallurgy, Operations & transport; filing pace dormant. Cited 27 times.

Investor mix

6 investors on record; lead investors include Mohr Davidow Ventures.

Investor typeCountShare
Venture capital6100%
Coming soon